Skip to main content Skip to section navigation Skip to footer
Careers News & Media Contact
OPKO Health, Inc. OPKO Health, Inc.
  • Therapies
    • Overview
    • Ngenla
    • Rayaldee
  • Research
    • Overview
    • Pipeline
    • Publications
    • Scientific Presentations
  • Diagnostics
  • Company
    • Overview
    • Leadership
    • Locations
  • Partnerships
  • Investors
    • Overview
    • News / Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • News & Media
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Presentations
  • Company Info
    • Overview
    • Proxy Materials
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Form 8937
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Nov 01, 2022 8:00am EDT

OPKO Health to Report Third Quarter 2022 Financial Results on November 8, 2022

Aug 16, 2022 4:29pm EDT

OPKO Health Announces Leadership Changes for BioReference Laboratories

Aug 04, 2022 4:05pm EDT

OPKO Health Reports 2022 Second Quarter Business Highlights and Financial Results

Jul 25, 2022 4:05pm EDT

OPKO Health to Report Second Quarter 2022 Financial Results on August 4, 2022

Jun 02, 2022 8:00am EDT

OPKO Health to Present at the 2022 Jefferies Healthcare Conference

May 09, 2022 4:05pm EDT

OPKO Health Reports 2022 First Quarter Business Highlights and Financial Results

May 09, 2022 9:23am EDT

OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases

May 05, 2022 4:05pm EDT

OPKO Health to Report First Quarter 2022 Financial Results on May 9, 2022

May 02, 2022 7:45am EDT

Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data Platforms

Feb 24, 2022 4:05pm EST

OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 52
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, FL 33137


T: 305-575-4100
contact@opko.com

©2025 OPKO Health, Inc. All Rights Reserved.
Privacy Policy Governance Terms of use Sitemap